| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JAM.12922 |
| P8608 | Fatcat ID | release_wiza5v4mdjf25pwcqph4xfktmi |
| P698 | PubMed publication ID | 26248815 |
| P2093 | author name string | H Jiang | |
| C Liu | |||
| Y Xu | |||
| F Xu | |||
| Y Ma | |||
| D Zhao | |||
| X Chen | |||
| L Jiang | |||
| C Jiang | |||
| L Bai | |||
| P Yang | |||
| S Sun | |||
| B Sun | |||
| W Kong | |||
| W Su | |||
| F T Kong | |||
| P2860 | cites work | Virology, epidemiology, pathogenesis, and control of enterovirus 71. | Q37801742 |
| The virology and developments toward control of human enterovirus 71. | Q37886179 | ||
| Large-scale production and purification of VLP-based vaccines | Q37904378 | ||
| Bioengineering virus-like particles as vaccines | Q38172045 | ||
| Evaluation of the stability of enterovirus 71 virus-like particle | Q39076793 | ||
| Complete genome analysis of the C4 subgenotype strains of enterovirus 71: predominant recombination C4 viruses persistently circulating in China for 14 years | Q41859348 | ||
| A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice | Q42211021 | ||
| Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71. | Q43941849 | ||
| Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. | Q44201038 | ||
| Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge | Q45396589 | ||
| Stabilization of human papillomavirus virus-like particles by non-ionic surfactants | Q45455736 | ||
| Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process. | Q50931193 | ||
| Ligands for mixed-mode protein chromatography: Principles, characteristics and design | Q28243473 | ||
| Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates | Q31056961 | ||
| Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice | Q33723474 | ||
| Expression, purification and characterization of enterovirus-71 virus-like particles | Q33788579 | ||
| Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay | Q33806668 | ||
| An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. | Q33875086 | ||
| Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system. | Q33908518 | ||
| An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China | Q33911890 | ||
| Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps | Q34603692 | ||
| An overview of the evolution of enterovirus 71 and its clinical and public health significance | Q34635602 | ||
| Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer. | Q36897382 | ||
| Progress on the research and development of inactivated EV71 whole-virus vaccines | Q37530094 | ||
| Development of enterovirus 71 vaccines. | Q37682898 | ||
| EV71: an emerging infectious disease vaccine target in the Far East? | Q37715371 | ||
| Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design | Q37792984 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1196-1205 | |
| P577 | publication date | 2015-08-06 | |
| P1433 | published in | Journal of Applied Microbiology | Q15756992 |
| P1476 | title | Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice | |
| P478 | volume | 119 |
| Q40113232 | Characterization of human enterovirus71 virus-like particles used for vaccine antigens. |
| Q97526333 | Integrated Process for Capture and Purification of Virus-Like Particles: Enhancing Process Performance by Cross-Flow Filtration |
| Q40458730 | Novel High-throughput Approach for Purification of Infectious Virions |
| Q91944141 | Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance |
| Q37060947 | Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles |
| Q92759317 | Purification of flavivirus VLPs by a two-step chomatographic process |
Search more.